{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:57:19Z","timestamp":1792670239751,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T00:00:00Z","timestamp":1265760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-22","type":"journal-article","created":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T19:15:57Z","timestamp":1265829357000},"source":"Crossref","is-referenced-by-count":92,"title":["African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults"],"prefix":"10.1186","volume":"10","author":[{"given":"Bradford D","family":"Gessner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seydou","family":"Yaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,10]]},"reference":[{"key":"1002_CR1","first-page":"93","volume":"82","author":"World Health Organization","year":"2007","unstructured":"World Health Organization: Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec. 2007, 82: 93-104.","journal-title":"Wkly Epidemiol Rec"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/S0140-6736(06)68703-5","volume":"367","author":"OS Levine","year":"2006","unstructured":"Levine OS, O'Brien KL, Knoll M, Adegbola RA, Black S, Cherian T, Dagan R, Goldblatt D, Grange A, Greenwood B, Hennessy T, Klugman KP, Madhi SA, Mulholland K, Nohynek H, Santosham M, Saha SK, Scott JA, Sow S, Whitney CG, Cutts F: Pneumococcal vaccination in developing countries. Lancet. 2006, 367: 1880-2. 10.1016\/S0140-6736(06)68703-5.","journal-title":"Lancet"},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","volume":"96","author":"AM Molesworth","year":"2002","unstructured":"Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, Shears P, Hart CA, Cuevas LE: Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg. 2002, 96: 242-9. 10.1016\/S0035-9203(02)90089-1.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1086\/506940","volume":"43","author":"S Yaro","year":"2006","unstructured":"Yaro S, Lourd M, Traor\u00e9 Y, Njanpop-Lafourcade BM, Sawadogo A, Sangare L, Hien A, Ouedraogo MS, Sanou O, Parent du Ch\u00e2telet I, Koeck JL, Gessner BD: Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis. 2006, 43: 693-700. 10.1086\/506940.","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"1002_CR5","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1086\/596498","volume":"48","author":"Y Traore","year":"2009","unstructured":"Traore Y, Tameklo TA, Njanpop-Lafourcade BM, Lourd M, Yaro S, Njamba D: Incidence, seasonality, age disgtribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo. Clin Infect Dis. 2009, 48 (suppl 2): S181-9. 10.1086\/596498.","journal-title":"Clin Infect Dis"},{"key":"1002_CR6","first-page":"P3","volume-title":"Anti-pneumococcal seroprevalence, and pneumococcal carriage and meningitis in Burkina Faso, 2006-7","author":"S Yaro","year":"2008","unstructured":"Yaro S, Mueller JE, Njanpop-Lafourcade BM, et al: Anti-pneumococcal seroprevalence, and pneumococcal carriage and meningitis in Burkina Faso, 2006-7. 2008, International Society for Prevention of Pneumococcal Disease conference, Reykjavik, Iceland, P3-016."},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/431151","volume":"192","author":"J Leimkugel","year":"2005","unstructured":"Leimkugel J, Adams Forgor A, Gagneux S, Pfl\u00fcger V, Flierl C, Awine E, Naegeli M, Dangy JP, Smith T, Hodgson A, Pluschke G: An outbreak of serotype 1 Streptococcus pneumoniae meningitis in Northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis. 2005, 192: 192-9. 10.1086\/431151.","journal-title":"J Infect Dis"},{"key":"1002_CR8","first-page":"499","volume":"77","author":"G Campagne","year":"1999","unstructured":"Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L, Chippaux JP: Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ. 1999, 77: 499-507.","journal-title":"Bull World Health Organ"},{"key":"1002_CR9","first-page":"575","volume":"59","author":"M Cadoz","year":"1981","unstructured":"Cadoz M, Denis F, Mar ID: Etude epidemiologique des cas de meningites purulentes hospitalises a Dakar pendant la decennie 1970-1979. Bull World Health Organ. 1981, 59: 575-84.","journal-title":"Bull World Health Organ"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1086\/507339","volume":"43","author":"Y Traor\u00e9","year":"2006","unstructured":"Traor\u00e9 Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, Drabo A, Parent du Ch\u00e2telet I, Mueller JE, Taha MK, Borrow R, Nicolas P, Alonso JM, Gessner BD: The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis. 2006, 43: 817-22. 10.1086\/507339.","journal-title":"Clin Infect Dis"},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(02)09458-8","volume":"360","author":"EM Molyneux","year":"2002","unstructured":"Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, Bwanaisa L, Njobvu A, Rogerson S, Malenga G: Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002, 360: 211-8. 10.1016\/S0140-6736(02)09458-8.","journal-title":"Lancet"},{"key":"1002_CR12","unstructured":"WHO Position Paper on Haemophilus influenzae type B conjugate vaccines. Wkly Epidemiol Rec. 2006, 47: 445-52."},{"key":"1002_CR13","volume-title":"Vaccines and Biologicals","author":"JV Bennett","year":"2002","unstructured":"Bennett JV, Platonov AE, Slack MP, Mala P, Burton A, Robertson SA: Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates. Vaccines and Biologicals. 2002, World Health Organization"},{"key":"1002_CR14","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.320.5884.1710","volume":"320","author":"L Roberts","year":"2008","unstructured":"Roberts L: An ill wind, bringing meningitis. Science. 2008, 320: 1710-5. 10.1126\/science.320.5884.1710.","journal-title":"Science"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1086\/518149","volume":"44","author":"WC Albrich","year":"2007","unstructured":"Albrich WC, Baughman W, Schmotzer B, Farley MM: Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2007, 44: 1569-76. 10.1086\/518149.","journal-title":"Clin Infect Dis"},{"key":"1002_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/infdis\/170.2.368","volume":"170","author":"M Davidson","year":"1994","unstructured":"Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ: The epidemiology of invasive pneumococcal disease in Alaska. J Infect Dis. 1994, 170: 368-76.","journal-title":"J Infect Dis"},{"key":"1002_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/infdis\/174.4.752","volume":"174","author":"KM Zangwill","year":"1996","unstructured":"Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI: Epidemiology of invasive pneumococcal diseases in Southern California: implications for the design and conduct of a pneumococcal conjugate vaccine trial. J Infect Dis. 1996, 174: 752-9.","journal-title":"J Infect Dis"},{"key":"1002_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archinte.1990.00390190067009","volume":"150","author":"RF Breiman","year":"1990","unstructured":"Breiman RF, Spkia JS, Navarro VJ, Darden PM, Darby CP: Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Int Med. 1990, 150: 1401-15. 10.1001\/archinte.150.7.1401.","journal-title":"Arch Int Med"},{"key":"1002_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1086\/514589","volume":"26","author":"P Pastor","year":"1998","unstructured":"Pastor P, Medley F, Murphy TV: Invasive pneumococcal disease in Dallas County, Texas; results from population-based surveillance in 1995. Clin Infect Dis. 1998, 26: 590-5. 10.1086\/514589.","journal-title":"Clin Infect Dis"},{"key":"1002_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5694\/j.1326-5377.1995.tb126016a.x","volume":"162","author":"PJ Torzillo","year":"1995","unstructured":"Torzillo PJ, Hanna JN, Morey F, Gratten M, Dixon J, Erlich J: Invasive pneumococcal disease in central Australia. Med J Austral. 1995, 162: 182-6.","journal-title":"Med J Austral"},{"key":"1002_CR21","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1001\/archinte.1992.00400230087015","volume":"152","author":"MM Cortese","year":"1992","unstructured":"Cortese MM, Wolff M, Almeido-Hill J, Reid R, Ketcham J, Santosham M: High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med. 1992, 152: 2277-82. 10.1001\/archinte.152.11.2277.","journal-title":"Arch Intern Med"},{"key":"1002_CR22","first-page":"P1","volume-title":"Burden and incidence of invasive pneumococcal disease among hospitalized adults in Kilifi, Kenya","author":"L Matata","year":"2008","unstructured":"Matata L, Ondieki C, Mutinda M, et al: Burden and incidence of invasive pneumococcal disease among hospitalized adults in Kilifi, Kenya. 2008, International Society for Prevention of Pneumococcal Disease conference, Reykjavik, Iceland, P1-108."},{"issue":"Suppl 2","key":"1002_CR23","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1086\/596495","volume":"48","author":"A Kisakye","year":"2009","unstructured":"Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, Wobudeya E, Chaplain D, Nalumansi E, Mbabazi W, Gessner BD: Surveillance for Streptococcus pneumoniae meningitis in children under 5 years of age: implications for immunization in Uganda. Clin Infect Dis. 2009, 48 (Suppl 2): S153-61. 10.1086\/596495.","journal-title":"Clin Infect Dis"},{"key":"1002_CR24","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","volume":"369","author":"DS Stephens","year":"2007","unstructured":"Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcemia, and Neisseria meningitidis. Lancet. 2007, 369: 2196-210. 10.1016\/S0140-6736(07)61016-2.","journal-title":"Lancet"},{"key":"1002_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1086\/313608","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Paradiso PR, Siber GR: Which pneumococcal serogroups cause the most invasive disease? Implications for conjugate vaccine formulations and use. Clin Infect Dis. 2000, 30: 100-21. 10.1086\/313608.","journal-title":"Clin Infect Dis"},{"key":"1002_CR26","first-page":"704","volume":"79","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB: Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001, 79: 704-12.","journal-title":"Bull World Health Organ"},{"key":"1002_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/136485907X154638","volume":"101","author":"J Makani","year":"2007","unstructured":"Makani J, Williams TN, Marsh K: Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol. 2007, 101: 3-14. 10.1179\/136485907X154638.","journal-title":"Ann Trop Med Parasitol"},{"key":"1002_CR28","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1016\/S0264-410X(02)00222-0","volume":"20","author":"A Dom\u00ednguez","year":"2002","unstructured":"Dom\u00ednguez A, Salleras L, Carde\u00f1osa N, Ciruela P, Carmona G, Mart\u00ednez A, Torner N, Fuentes M: The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study. Vaccine. 2002, 20: 2989-94. 10.1016\/S0264-410X(02)00222-0.","journal-title":"Vaccine"},{"key":"1002_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/PL00011269","volume":"20","author":"H Laurichesse","year":"2001","unstructured":"Laurichesse H, Romaszko JP, Nguyen LT, Souweine B, Poirier V, Gu\u00f3lon D, Andr\u00e9 M, Ruivard M, De Champs C, Caillaud D, Labb\u00e9 A, Beytout J: Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994-1998. Eur J Clin Micro Infect Dis. 2001, 20: 299-308.","journal-title":"Eur J Clin Micro Infect Dis"},{"key":"1002_CR30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","volume":"365","author":"FT Cutts","year":"2005","unstructured":"Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA, Gambian Pneumococcal Vaccine Trial Group: Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet. 2005, 365: 1139-46. 10.1016\/S0140-6736(05)71876-6.","journal-title":"Lancet"},{"key":"1002_CR31","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A: Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007, 297: 1784-92. 10.1001\/jama.297.16.1784.","journal-title":"JAMA"},{"key":"1002_CR32","volume-title":"Euro Surveill","author":"A Lepoutre","year":"2008","unstructured":"Lepoutre A, Varon E, Georges S, Gutmann L, L\u00e9vy-Bruhl D: Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill. 2008, 13:"},{"key":"1002_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/j.1469-0691.2008.02031.x","volume":"14","author":"SI Aguiar","year":"2008","unstructured":"Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese veillance Group for the Study of Respiratory Pathogens: Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect. 2008, 14: 835-43. 10.1111\/j.1469-0691.2008.02031.x.","journal-title":"Clin Microbiol Infect"},{"key":"1002_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","volume":"360","author":"HE Hsu","year":"2009","unstructured":"Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH: Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009, 360: 244-56. 10.1056\/NEJMoa0800836.","journal-title":"N Engl J Med"},{"key":"1002_CR35","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1016\/j.vaccine.2008.04.066","volume":"26","author":"M Saaka","year":"2008","unstructured":"Saaka M, Okoko BJ, Kohberger RC, Jaffar S, Enwere G, Biney EE, Oluwalana C, Vaughan A, Zaman SM, Asthon L, Goldblatt D, Greenwood BM, Cutts FT, Adegbola RA: Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine. 2008, 26: 3719-26. 10.1016\/j.vaccine.2008.04.066.","journal-title":"Vaccine"},{"key":"1002_CR36","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.vaccine.2003.03.001","volume":"22","author":"RE Huebner","year":"2004","unstructured":"Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP: Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine. Vaccine. 2004, 22: 2696-2700. 10.1016\/j.vaccine.2003.03.001.","journal-title":"Vaccine"},{"key":"1002_CR37","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","volume":"25","author":"SA Madhi","year":"2007","unstructured":"Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, Little T, Soininen A, Cutland C, Klugman KP: Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine. 2007, 25: 2451-7. 10.1016\/j.vaccine.2006.09.019.","journal-title":"Vaccine"},{"key":"1002_CR38","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","volume":"25","author":"GR Siber","year":"2007","unstructured":"Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R: Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine. 2007, 25: 3816-26. 10.1016\/j.vaccine.2007.01.119.","journal-title":"Vaccine"},{"key":"1002_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMoa035060","volume":"349","author":"KP Klugman","year":"2003","unstructured":"Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, Vaccine Trialists Group: A trial of 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003, 349: 1341-8. 10.1056\/NEJMoa035060.","journal-title":"N Engl J Med"},{"key":"1002_CR40","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.vaccine.2006.11.065","volume":"25","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Butler JC, Bulkow LR, Hurlburt D, O'Brien KL, Doan W, Parkinson AJ, Hennessy TW: Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults. Vaccine. 2007, 25: 2288-95. 10.1016\/j.vaccine.2006.11.065.","journal-title":"Vaccine"},{"key":"1002_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1442-200X.2008.02593.x","volume":"50","author":"D Scott","year":"2008","unstructured":"Scott D, Ruckle J, Dar M, Baker S, Kondoh H, Lockhart S: Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults. Pediatr Int. 2008, 50: 295-9. 10.1111\/j.1442-200X.2008.02593.x.","journal-title":"Pediatr Int"},{"key":"1002_CR42","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1086\/529142","volume":"46","author":"A de Roux","year":"2008","unstructured":"de Roux A, Schm\u00f6le-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM: Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis. 2008, 46: 1015-23. 10.1086\/529142.","journal-title":"Clin Infect Dis"},{"key":"1002_CR43","first-page":"893","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","unstructured":"Centers for Disease Control and Prevention: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005, 54: 893-97.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1002_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/506941","volume":"43","author":"PC Hill","year":"2006","unstructured":"Hill PC, Cheung YB, Akisanya A, Sankareh K, Lahai G, Greenwood BM, Adegbola RA: Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian Villagers. Clin Infect Dis. 2006, 43: 673-9. 10.1086\/506941.","journal-title":"Clin Infect Dis"},{"key":"1002_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/INF.0b013e31814da70c","volume":"27","author":"O Abdullahi","year":"2008","unstructured":"Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA: The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J. 2008, 27: 59-64. 10.1097\/INF.0b013e31814da70c.","journal-title":"Pediatr Infect Dis J"},{"key":"1002_CR46","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/315009","volume":"180","author":"N Mbelle","year":"1999","unstructured":"Mbelle N, Huebner RE, Wasa AD, Kimura A, Chang I, Klugman KP: Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999, 180: 1171-6. 10.1086\/315009.","journal-title":"J Infect Dis"},{"issue":"suppl","key":"1002_CR47","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","volume":"17","author":"DS Fedson","year":"1999","unstructured":"Fedson DS, Scott JA: The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine. 1999, 17 (suppl): S11-18. 10.1016\/S0264-410X(99)00122-X.","journal-title":"Vaccine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T21:54:38Z","timestamp":1558821278000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-22","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,10]]},"article-number":"22"}}